Literature DB >> 29279311

Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.

Arvind K Pandey1, Eric K Singhi1, Juan Pablo Arroyo1, Talat Alp Ikizler1, Edward R Gould1, Jonathan Brown1, Joshua A Beckman1, David G Harrison1, Javid Moslehi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29279311      PMCID： PMC5825002          DOI： 10.1161/HYPERTENSIONAHA.117.10271

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  77 in total

1.  Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells.

Authors:  Ingrid Fleming; Beate Fisslthaler; Madhulika Dixit; Rudi Busse
Journal:  J Cell Sci       Date:  2005-08-23       Impact factor: 5.285

2.  Bevacizumab, bleeding, thrombosis, and warfarin.

Authors:  Saadettin Kilickap; Huseyin Abali; Ismail Celik
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

3.  Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer.

Authors:  J Todd Belcik; Yue Qi; Beat A Kaufmann; Aris Xie; Sherry Bullens; Terry K Morgan; Susan P Bagby; Ganesh Kolumam; Joe Kowalski; Jon A Oyer; Stuart Bunting; Jonathan R Lindner
Journal:  J Am Coll Cardiol       Date:  2012-06-13       Impact factor: 24.094

Review 4.  Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

Authors:  Xiaolei Zhu; Shenhong Wu; William L Dahut; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

5.  Mechanisms of hypertension associated with BAY 43-9006.

Authors:  Maria Luisa Veronese; Ari Mosenkis; Keith T Flaherty; Maryann Gallagher; James P Stevenson; Raymond R Townsend; Peter J O'Dwyer
Journal:  J Clin Oncol       Date:  2006-01-30       Impact factor: 44.544

6.  The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.

Authors:  M Clauss; H Weich; G Breier; U Knies; W Röckl; J Waltenberger; W Risau
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

7.  Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice.

Authors:  T Meyer; L Robles-Carrillo; T Robson; F Langer; H Desai; M Davila; M Amaya; J L Francis; A Amirkhosravi
Journal:  J Thromb Haemost       Date:  2008-10-30       Impact factor: 5.824

8.  Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats.

Authors:  Jian-Wei Gu; R Davis Manning; Emily Young; Megan Shparago; Brandi Sartin; Amelia Purser Bailey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-06       Impact factor: 3.619

Review 9.  Platelet-derived nitric oxide signaling and regulation.

Authors:  Eugenia Gkaliagkousi; James Ritter; Albert Ferro
Journal:  Circ Res       Date:  2007-09-28       Impact factor: 17.367

10.  Endothelin-1 as a master regulator of whole-body Na+ homeostasis.

Authors:  Joshua S Speed; J Brett Heimlich; Kelly A Hyndman; Brandon M Fox; Vivek Patel; Masashi Yanagisawa; Jennifer S Pollock; Jens M Titze; David M Pollock
Journal:  FASEB J       Date:  2015-08-12       Impact factor: 5.191
View more
  55 in total

Review 1.  Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care.

Authors:  Ali Manouchehri; Elishama Kanu; Michael J Mauro; Aaron W Aday; Jonathan R Lindner; Javid Moslehi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-26       Impact factor: 8.311

Review 2.  Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.

Authors:  Umberto Campia; Javid J Moslehi; Laleh Amiri-Kordestani; Ana Barac; Joshua A Beckman; David D Chism; Paul Cohen; John D Groarke; Joerg Herrmann; Carolyn M Reilly; Neal L Weintraub
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 3.  Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?

Authors:  Hasitha Manohar; Adam S Potter; Efstratios Koutroumpakis; Anita Deswal; Nicolas L Palaskas
Journal:  Curr Atheroscler Rep       Date:  2022-05-28       Impact factor: 5.967

Review 4.  Arterial Thrombosis in Patients with Cancer.

Authors:  Mirela Tuzovic; Joerg Herrmann; Cezar Iliescu; Kostas Marmagkiolis; Boback Ziaeian; Eric H Yang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-07

5.  Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases.

Authors:  Rakeeb Kureshi; Angela Zhu; Jikui Shen; Stephany Y Tzeng; Leilani R Astrab; Paul R Sargunas; Jordan J Green; Peter A Campochiaro; Jamie B Spangler
Journal:  Cell Mol Bioeng       Date:  2020-07-31       Impact factor: 2.321

6.  Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial.

Authors:  Kaisa M Mäki-Petäjä; Adam McGeoch; Lucy L Yang; Annette Hubsch; Carmel M McEniery; Paul A R Meyer; Fraz Mir; Parag Gajendragadkar; Nicola Ramenatte; Gayathri Anandappa; Sara Santos Franco; Simon J Bond; Carola-Bibiane Schönlieb; Yoeri Boink; Christoph Brune; Ian B Wilkinson; Duncan I Jodrell; Joseph Cheriyan
Journal:  Hypertension       Date:  2021-03-29       Impact factor: 10.190

Review 7.  The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review.

Authors:  Qinchao Wu; Baochen Bai; Chao Tian; Daisong Li; Haichu Yu; Bingxue Song; Bing Li; Xianming Chu
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-13       Impact factor: 3.727

Review 8.  Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors.

Authors:  Melinda D Wu; Javid J Moslehi; Jonathan R Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-04       Impact factor: 8.311

9.  Red Blood Cells: Tethering, Vesiculation, and Disease in Micro-Vascular Flow.

Authors:  Robert J Asaro; Pedro Cabrales
Journal:  Diagnostics (Basel)       Date:  2021-05-27

10.  Interferon γ neutralization reduces blood pressure, uterine artery resistance index, and placental oxidative stress in placental ischemic rats.

Authors:  Olivia K Travis; Geilda A Tardo; Chelsea Giachelli; Shani Siddiq; Henry T Nguyen; Madison T Crosby; Tyler D Johnson; Andrea K Brown; George W Booz; Alex N Smith; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-06-02       Impact factor: 3.210
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.